Series A - Motif Neurotech

Series A - Motif Neurotech

Investment Firm

Overview

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.

Announced Date

Jan 24, 2024

Closed on Date

Jan 24, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Arboretum Ventures

Arboretum Ventures

Arboretum Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

11

Investor Name
Participant InvestorMax Hodak
Participant InvestorArboretum Ventures
Participant InvestorDolby Family Ventures
Participant InvestorCapital Factory
Participant InvestorSatori Capital

Round Details and Background

Motif Neurotech raised $18750000 on 2024-01-24 in Series A

Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 28, 2023
Seed Round - Motif Neurotech
3-100.0K
Jan 24, 2024
Series A - Motif Neurotech
11-18.8M

Recent Activity

There is no recent news or activity for this profile.